Clinical Notes
TMJ BOTOX
COVID-19 SCREENING
----------------------------------
Patient was pre-screened per OS protocol prior to appointment.
Patient was additionally screening via phone when they arrived outside the practice and temperature was checked.
COVID-19 Consent was completed in addition all OS paperwork . Patient signature was verified.
Room was disinfected using Super Sani-Cloth Germicidal Disposable Wipe (EPA Reg # 9480-4 ) techniques per manufactures protocols, followed by Clorox® Clean-Up® Cleaner + Bleach (EPA Reg. No. 5813-21) Spray and room dry. Room was verified by the other assistant for completion via COVID-19 Room disinfection checklist.
Patient also rinsed with 1.5% hydrogen peroxide for 30 second
Progress Note
------------------
Patient seen and consulted on previous visit for TMJ Disorder
where Botox was recommended
Patient here today to get the Botox A treatment. All risk, benefit, complications discussed. Consent obtained
ASSESSMENT / PLAN / RECOMMENDATION
---------------------------------------------------------------
BOTOX Injection - 200 Units Type A
Masseter R : 35U Masseter L : 35U
Temporalis R : 15U Temporalis R : 15U
Descending Trapezius
Superior portion R :15U L :15U
Middle Portion R :5U L :5U
Lower Portion R :20U L :20U
Transverse Trapezius
Medial Portion R: 10 L : 10U
Patient to Follow-up in 1 month
Joseph Krajekian DMD, MD, FAAOMS, DABOMS